$45.40
1.96[4.51%]
At close: May 6
$45.40
0[0.00%]
After Hours: 5:47PM EDT
Vera Therapeutics
(NASDAQ:VERA)Latest News for Vera Therapeutics Stock (NASDAQ:VERA)
Vera Therapeutics Stock (NASDAQ: VERA)
Categories: All
Thursday, April 11, 2024
- Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential ImpactVandana Singh - Apr 11, 2024, 2:47PM
- Vera Therapeutics shares are trading higher in sympathy with Alpine Immune, which entered an agreement to be acquired by Vertex.Benzinga Newsdesk - Apr 11, 2024, 7:35AM
- Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Apr 11, 2024, 6:14AM
Wednesday, April 10, 2024
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga Insights - Apr 10, 2024, 4:31PM
- Vera Therapeutics shares are trading higher in sympathy with Alpine Immune, which gained amid takeover rumors.Benzinga Newsdesk - Apr 10, 2024, 3:35PM
- Watching Vera Therapeutics; Traders Circulating Share Price Moved Higher In Sympathy With Alpine Immune Report Suggesting The Co Is Weighing Options After Takeover InterestBenzinga Newsdesk - Apr 10, 2024, 12:53PM
Friday, April 05, 2024
Wednesday, March 27, 2024
Thursday, March 21, 2024
Wednesday, March 20, 2024
Friday, February 02, 2024
Wednesday, January 31, 2024
Tuesday, January 30, 2024
Monday, January 29, 2024
Friday, January 26, 2024
- Analyst Highlights 'Rock Solid' Data For Vera Therapeutics' Kidney Disease-Targeted Atacicept, Upgrades To Strong BuyVandana Singh - Jan 26, 2024, 2:54PM
- What's Going On With Vera Therapeutics Stock Today?Vandana Singh - Jan 26, 2024, 2:13PM
- Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Jan 26, 2024, 1:17PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Jan 26, 2024, 12:31PM
- Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet (Donald Trump Has Re-Entered The Chat)Chris Katje - Jan 26, 2024, 11:50AM
- Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On FridayAvi Kapoor - Jan 26, 2024, 10:30AM
- Vera Therapeutics shares are trading higher after the company on Thursday reported data from its Phase 2b ORIGIN clinical trial. Raymond James upgraded the stock to Strong Buy.Benzinga Newsdesk - Jan 26, 2024, 10:25AM
- Wedbush Maintains Neutral on Vera Therapeutics, Raises Price Target to $21Benzinga Newsdesk - Jan 26, 2024, 8:36AM
- Raymond James Upgrades Vera Therapeutics to Strong Buy, Raises Price Target to $37Benzinga Newsdesk - Jan 26, 2024, 7:39AM
Thursday, January 25, 2024
- Nasdaq Edges Lower; American Airlines Posts Upbeat EarningsAvi Kapoor - Jan 25, 2024, 3:18PM
- Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Jan 25, 2024, 2:52PM
- Why Is Immunology Disease Focused Vera Therapeutics Stock Trading Higher Today?Vandana Singh - Jan 25, 2024, 2:07PM
- Alaska Air Posts Upbeat Earnings, Joins Xerox, United Rentals And Other Big Stocks Moving Higher On ThursdayAvi Kapoor - Jan 25, 2024, 1:26PM
- Crude Oil Rises 2%; Tesla Shares Plunge After Downbeat ResultsAvi Kapoor - Jan 25, 2024, 1:08PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Jan 25, 2024, 12:31PM
- Vera Therapeutics shares are trading lower after the company announced 72-week data from the OLE period of its Phase 2b ORIGIN clinical trial. Also, Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $26 price target.Benzinga Newsdesk - Jan 25, 2024, 10:51AM
- Vera Therapeutics, Says It Presented Positive 72-Week Data Showing eGFR Stabilization In Phase 2b ORIGIN Clinical Trial OLE in IgA NephropathyBenzinga Newsdesk - Jan 25, 2024, 6:41AM
- Oppenheimer Initiates Coverage On Vera Therapeutics with Outperform Rating, Announces Price Target of $26Benzinga Newsdesk - Jan 25, 2024, 4:54AM
Monday, January 08, 2024
- Cantor Fitzgerald Initiates Coverage On Vera Therapeutics with Overweight RatingBenzinga Newsdesk - Jan 8, 2024, 11:37AM
- Vera Therapeutics To Host In-Person R&D Day In New York To Present Week 72 Data From Phase 2b ORIGIN Clinical Trial Of Atacicept In IgAN On January 25, 2024Benzinga Newsdesk - Jan 8, 2024, 8:16AM